Platelet Rich Plasma Market Report, By Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), Application (Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Others), End User (Hospitals and Clinics, Research Institutes) and Geography - Global market share, Trend Analysis and Forecast

Platelet-Rich Plasma (PRP) is a low-cost procedure to deliver high concentrations of autologous growth factors (GFs). Platelet activation is a crucial step that might influence the availability of bioactive molecules and therefore tissue healing. Platelet-rich plasma market remains impacted by its necessary use in the healthcare industry, particularly in orthopedic medical procedures and corrective medical procedures. Wounds like rotator cuff, tendon injuries, tennis elbow and hamstring among others are repaired rapidly and adequately with the assistance of platelet-rich plasma treatment. Additionally, platelet rich plasma therapy is also utilised in treating various sports injuries. Treatment with PRP hold promise with minimal risks associated with it. 

Platelet Rich Plasma Market Driving Factors

The major factors that drives the platelet rich plasma market include rise  in geriatric population, growing  incidence of sports and orthopedic injuries coupled with the high growth in  cosmetic surgical procedures etc. As indicated by American Society of Plastic Surgeons, about 17.7 million cosmetic surgeries were done in the year 2018 which is approximate 2% rise from 2017. The growing popularity of cosmetic surgeries will drive the demand of platelet rich plasma market. PRP products are widely used in cosmetic surgeries to improve facial aesthetics, enhance the rate of injury healing and modify facial structure . 

Platelet Rich Plasma Market Challenging Factors

The High cost of platelet rich plasma treatment, coupled with the limited reimbursement coverage of platelet-rich plasma products and therapies, is likely to limit the global platelet rich plasma market growth. The average price of PRP injections starts from USD 200 to USD 800, based on the application area and it needs repeated dose of injection which increase the overall platelet rich plasma treatment cost 

Platelet Rich Plasma Market Segmental Highlights

The report analyses the global Platelet Rich Plasma market based on product, application, and geography.

• The various types if platelet-rich has been bifurcated into pure platelet rich plasma, leukocyte-rich platelet-rich plasma, and pure platelet-rich fibrin. Pure PRP  is a platelet rich plasma preparation that contains highly concentrated platelet growth factors with reduced red blood cells. The absence of red cells improved the overall treatment as RBS”s have no therapeutic effect and also contain inflammatory components, which might increase pain post treatment. Pure platelet-rich plasma type is likely to hold major market share owing to its widespread use in various applications and rich content of platelets. 
• The platelet rich plasma market finds major application in orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, etc.  Cosmetic Surgery application offers lucrative opportunity to the growth of the market owing to  increase in the applications of platelet-rich plasma products in hair transplant and other cosmetic applications drive the cosmetic surgery segment of the global platelet-rich plasma market. Whereas, orthopedic application is likely to have highest demand for the platelet rich plasma treatment on the account if high number if orthopedic surgeries and sports injuries
• The major end users of plasma rich platelets are hospitals and clinics, research institutes. Where, The hospitals end user segment accounted for major  revenue share of the platelet-rich plasma market.
• Platelet Rich Plasma market is studied for the key regions including North America, Europe, Asia Pacific, and Rest of the World. North America’s platelet-rich plasma market is expected to remain the most attractive, growing at a robust CAGR through the forecast period.  Factors such as increasing number of cosmetic and orthopedic surgeries, presence of key players in the region and strong awareness about PRP therapy and devices are supporting the dominance of the region. 

Platelet Rich Plasma Market Key Players 

• Arthrex, Inc.
• Zimmer Biomet
• Harvest Technologies Corporation
• DePuy Synthes, Inc.
• Stryker Corporation
• AdiStem Ltd.
• ISTO Biologics
• Cesca Therapeutics, Inc.
• Exactech Inc.
• Nuo Therapeutics

Platelet Rich Plasma Market Key Developments

• January 2020: Crown Aesthetics, a division of Crown Laboratories, Inc., introduced  ProGen PRP™ Advantage, an easy to use, single spin system that features 15ml and 30ml tubes, yielding 7-15ml of 2x concentration PRP. With the launch of ProGen PRP™ Advantage, physicians will now be able to deliver Platelet Rich Plasma procedures more efficiently and conveniently.
• July 2019: Adimarket, LLC, a subsidiary of the Global Stem Cells Group, introduced new platelet-rich plasma (PRP) product, that is a viable treatment option in a host of regenerative medicine sectors.  With this launch, Adimarket will provide physicians with an exciting treatment protocol that can deliver relief to patients needing critical aesthetic, wound, and orthopedic care.
• August 2017:  Cesca Therapeutics, Inc. entered into a distribution agreement with Boyalife WSN Ltd. for sale and marketing of its bio-banking and point-of-care solutions in China, India, Singapore, and the Philippines.